Author

Megan Fuller

BC Cancer – VictoriaORCID 0000-0002-8752-8312Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alexi S. Pearson-LundiD· 1 shared Brad H. NelsoniD· 1 shared Cameron J. PowelliD· 1 shared Danielle KlasseniD· 1 shared Julian C SmazynskiiD· 1 shared Kassandra Sewell· 1 shared Katy MilneiD· 1 shared Marco Joly· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alexi S. Pearson-LundORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Engineered T cells controlled by granulocyte colony-stimulating factor eradicate murine melanoma without lymphodepletion or interleukin-2

Sam C Preshaw, Megan Fuller, Cameron J. Powell, Katy Milne, Kassandra Sewell, Mitchell Brady Adamson, Alexi S. Pearson-Lund, Marco Joly, Sydney Goodwin, Niloufar Shakerian, Natalie J.S. Taylor, Ming Zi Xu, Danielle Klassen, Taise Bryce, Julian C Smazynski, , Brad H. Nelson

This study engineers T cells to respond to G-CSF instead of IL-2, enabling effective melanoma treatment without lymphodepletion or IL-2.

bioRxiv · Oct 28, 2026 · PreprintImmunology